Legend Biotech (LEGN) Current Assets (2019 - 2026)

Legend Biotech (LEGN) has 8 years of Current Assets data on file, last reported at $1.1 billion in Q1 2026.

• Quarterly Current Assets fell 11.17% year-over-year to $1.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (down 11.17% YoY) and the FY2025 annual result came in at $1.2 billion, down 2.87% from the prior year.
• Current Assets fell to $1.1 billion in Q1 2026, from $1.2 billion in the prior quarter.
• In the past five years, Current Assets ranged from a high of $1.6 billion in Q2 2023 to a low of $864.4 million in Q1 2022.
• A 5-year average of $1.3 billion and a median of $1.2 billion in 2025 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2022 — Current Assets surged 181849.97% — and 2024, when it slipped 14.28%.
• Tracing LEGN's Current Assets over 5 years: stood at $1.1 billion in 2022, then jumped by 36.27% to $1.5 billion in 2023, then slipped by 14.28% to $1.3 billion in 2024, then dropped by 2.87% to $1.2 billion in 2025, then dropped by 13.18% to $1.1 billion in 2026.
• The last three Current Assets figures came in at $1.1 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.2 billion (Q3 2025), per Business Quant data.